1. Laboratory diagnostics in hematology—a new “Educational” series

   • Gerald Webersinke

   editorial 13 April 2018 Pages: 81 - 81

2. The adolescence of cancer immunotherapy: from a difficult childhood to a pillar of modern anticancer therapy

   • Thorsten Fuereder

   editorial 24 May 2018 Pages: 82 - 83

3. Update and clinical highlights presented at the 2017 American Society of Hematology Meeting

   • Daniel Heintel

   editorial 01 June 2018 Pages: 84 - 84

4. Educational no. 1: Bone marrow diagnostics in hemato-oncological diseases

   • Michael Vockenhuber
   • Kurt Wiesinger
   • Christine Gruber

   educational 13 April 2018 Pages: 85 - 88

   

5. Update of clinical highlights presented at the 2017 American Society of Hematology Meeting

   • Sabine Burger
   • Niklas Zojer
   • Heinz Ludwig

   short review 06 June 2018 Pages: 89 - 93

   

6. ASH 2017: highlights in chronic myeloid leukemia

   • Klaus Geissler

   short review 23 May 2018 Pages: 94 - 96

7. Acute myeloid leukemia—current data from the 2017 American Society of Hematology meeting

   • Michael Pfeilstöcker

   short review 25 May 2018 Pages: 97 - 100

8. Indolent lymphoma at ASH (American Society of Hematology) 2017: maintenance revisited

   • Thomas Nösslinger

   short review 21 March 2018 Pages: 101 - 104

   

9. Chronic lymphocytic leukemia at ASH 2017

   • David Wanner
   • Michael Steurer

   short review Open access 01 June 2018 Pages: 105 - 108

10. My burning issues in aggressive Non Hodgkin’s Lymphoma

    • David Fuchs
    • Michael A. Fridrik

    special report 28 May 2018 Pages: 109 - 111

11. Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives

    • Andreas Tiefenbacher
    • Robert Pirker

    short review Open access 18 May 2018 Pages: 112 - 115

12. Chimeric antigen receptor T‑cell therapy—a hematological success story

    • Philipp Wohlfarth
    • Nina Worel
    • Georg Hopfinger

    short review Open access 06 June 2018 Pages: 116 - 121

    

13. Current and future developments of immunotherapy in lung cancer

    • Laetitia A. Mauti
    • Tobias Finazzi
    • Sacha I. Rothschild

    review 23 May 2018 Pages: 122 - 131

14. Management of adverse events related to checkpoint inhibition therapy

    • Jakob Daniel Rudzki

    short review Open access 12 June 2018 Pages: 132 - 137

15. Pitfalls in the radiological response assessment of immunotherapy

    • Lucian Beer
    • Maximilian Hochmair
    • Helmut Prosch

    short review Open access 21 March 2018 Pages: 138 - 143

    

16. APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania

    • Nicoleta Mariana Berbec
    • Dana Lucia Stanculeanu
    • Alexandru Iordan

    original report Open access 02 March 2018 Pages: 144 - 151

    

17. JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms

    • Soheila Bagheropur
    • Ali Ehsanpour
    • Najmaldin Saki

    review 22 March 2018 Pages: 152 - 157

18. Pulmonary mass: never judge a book by its cover

    • Inke De haes
    • Yvan Valcke
    • Pieter Goeminne

    case report 23 April 2018 Pages: 158 - 160

    

19. Developments in neuro-oncology

    • Silvia Hofer

    comment – reprint 30 August 2016 Pages: 161 - 162